Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate cancer update: 2006.

Amy M Lin1, Eric J Small

  • 1UCSF Comprehensive Cancer Center, University of California, San Francisco, California 94115, USA. amlin@medicine.ucsf.edu

Current Opinion in Oncology
|April 7, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Convergent evolution of complex structural variants drives therapy resistance in metastatic prostate cancer.

Genome biology·2026
Same author

Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials.

Cancer·2025
Same author

A roadmap for future clinical research in advanced prostate cancer: Findings from the Advanced Prostate Cancer Consensus Conference (APCCC) 2024.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer.

Nature communications·2025
Same author

Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer.

Nature genetics·2025
Same author

Utility of metastasis-directed radiotherapy with and without hormonal therapy in management of oligometastatic prostate cancer.

JNCI cancer spectrum·2025
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Recent prostate cancer research shows finasteride may improve PSA test accuracy. Immediate androgen deprivation therapy benefits survival for advanced cases, but carries risks. Immunotherapy shows promise for advanced disease.

Area of Science:

  • Urology
  • Oncology
  • Medical Research

Background:

  • Prostate cancer remains a significant health concern.
  • Ongoing research is crucial for improving patient outcomes.

Purpose of the Study:

  • To review key advancements in prostate cancer diagnosis, prevention, and treatment.
  • To synthesize findings from the past year's medical literature.

Main Methods:

  • Literature review of recent publications.
  • Analysis of clinical trial data and observational studies.

Main Results:

  • High rates of prostate-specific antigen (PSA) screening in elderly men observed.
  • Finasteride may enhance PSA test sensitivity for prostate cancer detection.

Related Experiment Videos

  • Immediate androgen deprivation therapy improves survival in locally advanced prostate cancer but increases cardiovascular and diabetes risks.
  • Adjuvant radiotherapy shows no survival benefit for high-risk disease.
  • Definitions for biochemical failure proposed for post-treatment relapse.
  • Immunotherapy demonstrates preliminary survival benefit in advanced prostate cancer.

    • Conclusions:

    • Recent findings have significant implications for prostate cancer management.
    • Updates impact primary care physicians, medical oncologists, urologists, and radiation oncologists.
    • Continued research is vital for refining treatment strategies and patient care.